SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,185 | -53.2% | 30,318 | +1.5% | 0.00% | – |
| Q2 2023 | $38,837 | -19.6% | 29,875 | +8.9% | 0.00% | – |
| Q1 2023 | $48,279 | -50.0% | 27,431 | -10.9% | 0.00% | – |
| Q4 2022 | $96,624 | -27.9% | 30,772 | +12.9% | 0.00% | -100.0% |
| Q3 2022 | $134,000 | +28.8% | 27,261 | +9.6% | 0.00% | – |
| Q2 2022 | $104,000 | -52.1% | 24,879 | -33.5% | 0.00% | – |
| Q1 2022 | $217,000 | -37.6% | 37,394 | -19.5% | 0.00% | -100.0% |
| Q4 2021 | $348,000 | -16.5% | 46,452 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $417,000 | -38.1% | 46,267 | -17.9% | 0.00% | -50.0% |
| Q2 2021 | $674,000 | +6.3% | 56,348 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $634,000 | -14.2% | 50,588 | +6.9% | 0.00% | -33.3% |
| Q4 2020 | $739,000 | +112.4% | 47,332 | +28.5% | 0.00% | +50.0% |
| Q3 2020 | $348,000 | +1.8% | 36,836 | -3.5% | 0.00% | 0.0% |
| Q2 2020 | $342,000 | +137.5% | 38,161 | +68.3% | 0.00% | +100.0% |
| Q1 2020 | $144,000 | -57.6% | 22,671 | -44.2% | 0.00% | -50.0% |
| Q4 2019 | $340,000 | -15.4% | 40,644 | -8.5% | 0.00% | 0.0% |
| Q3 2019 | $402,000 | -15.9% | 44,397 | -0.1% | 0.00% | -33.3% |
| Q2 2019 | $478,000 | +9.6% | 44,428 | -2.8% | 0.00% | 0.0% |
| Q1 2019 | $436,000 | -16.2% | 45,710 | +0.9% | 0.00% | -25.0% |
| Q4 2018 | $520,000 | -43.0% | 45,295 | -15.9% | 0.00% | -33.3% |
| Q3 2018 | $913,000 | +14.8% | 53,866 | -3.8% | 0.01% | +20.0% |
| Q2 2018 | $795,000 | -16.0% | 56,015 | +12.5% | 0.01% | -16.7% |
| Q1 2018 | $946,000 | -0.5% | 49,797 | -14.1% | 0.01% | -14.3% |
| Q4 2017 | $951,000 | +20.1% | 57,984 | +9.8% | 0.01% | 0.0% |
| Q3 2017 | $792,000 | +108.4% | 52,791 | +22.1% | 0.01% | +75.0% |
| Q2 2017 | $380,000 | +59.7% | 43,231 | -5.7% | 0.00% | +100.0% |
| Q1 2017 | $238,000 | +35.2% | 45,821 | -20.7% | 0.00% | 0.0% |
| Q4 2016 | $176,000 | -26.1% | 57,810 | +12.5% | 0.00% | -33.3% |
| Q3 2016 | $238,000 | -32.6% | 51,388 | -15.7% | 0.00% | -40.0% |
| Q2 2016 | $353,000 | -3.8% | 60,971 | +0.6% | 0.01% | 0.0% |
| Q1 2016 | $367,000 | -39.5% | 60,606 | -8.8% | 0.01% | -28.6% |
| Q4 2015 | $607,000 | +79.6% | 66,461 | +10.9% | 0.01% | +40.0% |
| Q3 2015 | $338,000 | -52.7% | 59,924 | -6.9% | 0.01% | -50.0% |
| Q2 2015 | $714,000 | -33.9% | 64,379 | -6.5% | 0.01% | -23.1% |
| Q1 2015 | $1,080,000 | +18.6% | 68,864 | +15.0% | 0.01% | +18.2% |
| Q4 2014 | $911,000 | +36.0% | 59,895 | -3.6% | 0.01% | +22.2% |
| Q3 2014 | $670,000 | -41.0% | 62,114 | -16.5% | 0.01% | -40.0% |
| Q2 2014 | $1,136,000 | -42.8% | 74,377 | -32.3% | 0.02% | -40.0% |
| Q1 2014 | $1,986,000 | +351.4% | 109,828 | +246.8% | 0.02% | +257.1% |
| Q4 2013 | $440,000 | -20.7% | 31,666 | -40.2% | 0.01% | -46.2% |
| Q3 2013 | $555,000 | +59.9% | 52,954 | +19.1% | 0.01% | +85.7% |
| Q2 2013 | $347,000 | – | 44,477 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |